We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$44.3B
AUM Growth
-$9.51B
Cap. Flow
-$5.48B
Cap. Flow %
-12.38%
Top 10 Hldgs %
12.78%
Holding
2,408
New
212
Increased
800
Reduced
967
Closed
238

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$1.01B
2
NBIS
Nebius Group N.V.
NBIS
+$257M
3
CVX icon
Chevron
CVX
+$236M
4
XOM icon
ExxonMobil
XOM
+$224M
5
ABBV icon
AbbVie
ABBV
+$184M

Sector Composition

Rank Sector Weight
1 Healthcare 22.65%
2 Technology 17.13%
3 Financials 12.56%
4 Consumer Discretionary 8.83%
5 Industrials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNCE
2151
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$1K ﹤0.01%
239
-2,025
-89% -$6.42K
SRNE
2152
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$1K ﹤0.01%
+2
New +$6
VLDR
2153
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$1K ﹤0.01%
+69
New +$236
QUMU
2154
DELISTED
Qumu Corp.
QUMU
$1K ﹤0.01%
+465
New +$868
AGTC
2155
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1K ﹤0.01%
122
-1,795
-94% -$3.26K
LOGC
2156
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1K ﹤0.01%
+526
New +$577
FMTX
2157
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1K ﹤0.01%
+46
New +$490
CNVY
2158
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$1K ﹤0.01%
3
-59,997
-100% -$396K
MNDT
2159
DELISTED
Mandiant, Inc. Common Stock
MNDT
$1K ﹤0.01%
1
CALA
2160
DELISTED
Calithera Biosciences, Inc
CALA
$1K ﹤0.01%
71
BLPH
2161
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1K ﹤0.01%
153
-11
-7% -$26
GNCA
2162
DELISTED
Genocea Biosciences, Inc.
GNCA
$1K ﹤0.01%
905
-132
-13% -$144
ONCS
2163
DELISTED
OncoSec Medical Incorporated
ONCS
$1K ﹤0.01%
15
+8
+114% +$169
MACK
2164
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1K ﹤0.01%
91
EMKR
2165
DELISTED
Emcore Corp
EMKR
$1K ﹤0.01%
+3
New +$144
CEMI
2166
DELISTED
Chembio diagnostics, Inc.
CEMI
$1K ﹤0.01%
1,392
+1,301
+1,430% +$1.21K
ABG icon
2167
Asbury Automotive
ABG
$3.73B
-14,396
Closed -$2.49M
ACHR icon
2168
Archer Aviation
ACHR
$4.14B
-1,000,000
Closed -$6.04M
ADV icon
2169
Advantage Solutions
ADV
$425M
0
-$1K
AFMD
2170
DELISTED
Affimed
AFMD
-363
Closed -$20K
AFYA icon
2171
Afya
AFYA
$1.21B
-38,000
Closed -$597K
AGIO icon
2172
Agios Pharmaceuticals
AGIO
$1.98B
-140
Closed -$5K
AGL icon
2173
Agilon Health
AGL
$1.55B
-12,003
Closed -$8.1M
AHT
2174
Ashford Hospitality Trust
AHT
$20.1M
-6
Closed -$1K
ALNY icon
2175
Alnylam Pharmaceuticals
ALNY
$32.5B
-992,180
Closed -$168M

Similar funds

Federated Hermes's Q1 2022 Portfolio in Review

As of Q1 2022, Federated Hermes held 2,408 positions worth $44.3B, down 18% from $53.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes withdrew a net $5.48B in Q1 2022, closing 238 positions and reducing 967 holdings. Its most notable exit was Nebius Group N.V., an estimated $257M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Financials.

Against the trend, Federated Hermes opened a new position in Apollo Global Management worth $44.5M.

  • Federated Hermes's largest Q1 2022 buy was Apollo Global Management: 718,400 shares worth $44.5M.
  • Federated Hermes added most to Clorox in Q1 2022, an estimated $160M increase.
  • Federated Hermes's biggest Q1 2022 reduction was TSMC, cutting an estimated $1.01B.
  • Federated Hermes fully exited Nebius Group N.V. in Q1 2022, selling an estimated $257M.
  • Federated Hermes's ten largest holdings make up 13% of its $44.3B portfolio in Q1 2022.
  • Federated Hermes opened 212 new positions and closed 238 in Q1 2022.
  • Federated Hermes's portfolio value fell 18% quarter-over-quarter to $44.3B.

Based on Federated Hermes's 13F filing for Q1 2022, filed 13 May 2022.